Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study

Milly Buwenge, Francesco Deodato, Gabriella Macchia, Giambattista Siepe, Xiao Zhao, Richard K. Valicenti, Savino Cilla, Anna Rita Alitto, Maria Ntreta, Silvia Bisello, Giovanna Mantini, Vincenzo Valentini, Alessio G. Morganti, Silvia Cammelli

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

BACKGROUND/AIM: Radiotherapy (RT) with adjuvant hormone therapy (HT) improves prognosis in prostate cancer (PC) patients. Gonadotrophin-releasing hormone agonist (GnRHa) with luteinizing hormone-releasing hormone (LH-RH) analogues is the standard HT. High-dose antiandrogen therapy also improves survival in patients with locally advanced PC. The aim of this study was to compare the results of patients treated with RT plus GnRHa and patients treated with RT plus bicalutamide. PATIENTS AND METHODS: Our institutional PC database was used to identify patients treated with definitive or postoperative RT +/- HT which were included in this study. RESULTS: Three hundred and eighteen patients were retrospectively reviewed (median follow-up=56 months). Five-year biochemical relapse-free survival was 85.5% and 88.3% in patients treated with GnRHa and bicalutamide, respectively (p=0.712). CONCLUSION: Bicalutamide may be offered as an adjuvant treatment to RT in patients who refuse GnRHa because of related side effects. Furthermore, our study justifies randomized trials comparing RT plus GnRHa and RT plus bicalutamide.

Original languageEnglish (US)
Pages (from-to)6373-6378
Number of pages6
JournalAnticancer research
Volume39
Issue number11
DOIs
StatePublished - Nov 1 2019

Keywords

  • adjuvant hormonal therapy
  • bicalutamide
  • gonadotrophin-releasing hormone agonist
  • Prostate neoplasm
  • radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study'. Together they form a unique fingerprint.

  • Cite this

    Buwenge, M., Deodato, F., Macchia, G., Siepe, G., Zhao, X., Valicenti, R. K., Cilla, S., Alitto, A. R., Ntreta, M., Bisello, S., Mantini, G., Valentini, V., Morganti, A. G., & Cammelli, S. (2019). Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study. Anticancer research, 39(11), 6373-6378. https://doi.org/10.21873/anticanres.13850